Trial results

$RARE — DTX301

Ultragenyx Pharmaceutical Inc. (RARE) DTX301: trial results in OTC deficiency, 2027.

Research by Catalyst Intel

The catalyst

"Data are expected in the first half of 2027."

— Ultragenyx Pharmaceutical Inc., 10-Q filed 2026-11-04 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

RARE-DTX301-2026

Company

Ultragenyx Pharmaceutical Inc.

Kind

Trial results

Indication

OTC deficiency

Window

2027-01-01 – 2027-06-30

Status

dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.